← Evidence map

ReviewBritish journal of haematology2026

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis.

Jennifer O'Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39604140